Yang, S C <br/><br/>
Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.  [electronic resource] 

 -  Cancer research  Jul 1991 
 - 3669-76 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antigens, Surface--analysis<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--immunology<br/>Drug Evaluation<br/>Humans<br/>Interleukin-2--administration & dosage<br/>Killer Cells, Lymphokine-Activated--immunology<br/>Killer Cells, Natural--immunology<br/>Lung Neoplasms--immunology<br/>Middle Aged<br/>T-Lymphocytes--immunology<br/>Tumor Necrosis Factor-alpha--administration & dosage